Publisher
Cambridge University Press
Reference4 articles.
1. Symptomatic amyloid-related imaging abnormalities in an APOE ε4/ε4 patient treated with aducanumab;VandeVrede;Alzheimers Dement,2020
2. Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis
3. 1 AHEAD Study. Lecanemab for people with increased risk of Alzheimer’s disease. www.alzheimers.gov/clinical-trials/ahead-study-ban2401-people-increased-risk-alzheimers-disease (accessed 2/12/2023).
4. Multiple Cerebral Hemorrhages in a Patient Receiving Lecanemab and Treated with t-PA for Stroke